ANIXA BIOSCIENCES, INC. Deferred Tax Assets, Goodwill and Intangible Assets
ANIXA BIOSCIENCES, INC. (ANIX) had Deferred Tax Assets, Goodwill and Intangible Assets of $104.00 thousand as of 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2026-01-12
- 2025-10-31: Deferred Tax Assets, Goodwill and Intangible Assets $104.00K.
- 2024-10-31: Deferred Tax Assets, Goodwill and Intangible Assets $161.00K; Deferred Tax Assets, Goodwill and Intangible Assets as first filed $161.00M.
- 2023-10-31: Deferred Tax Assets, Goodwill and Intangible Assets $218.00M.
- 2022-10-31: Deferred Tax Assets, Goodwill and Intangible Assets $274.00M; Deferred Tax Assets, Goodwill and Intangible Assets as first filed $274.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets | Deferred Tax Assets, Goodwill and Intangible Assets as first filed |
|---|---|---|
| 2025-10-31 | $104.00K 10-K · filed 2026-01-12 | |
| 2024-10-31 | $161.00K 10-K · filed 2026-01-12 | $161.00M 10-K · filed 2025-01-10 |
| 2023-10-31 | $218.00M 10-K · filed 2025-01-10 | |
| 2022-10-31 | $274.00M 10-K · filed 2024-01-16 | $274.00K 10-K · filed 2023-01-04 |
| 2021-10-31 | $330.00K 10-K · filed 2023-01-04 | |
| 2020-10-31 | $828.00K 10-K · filed 2022-01-04 | |
| 2019-10-31 | $943.00K 10-K · filed 2021-01-07 | |
| 2018-10-31 | $754.00K 10-K · filed 2020-01-09 | |
| 2017-10-31 | $543.00K 10-K · filed 2019-01-11 | |
| 2016-10-31 | $713.00K 10-K · filed 2018-01-09 | |
| 2015-10-31 | $483.00K 10-K · filed 2016-12-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |